Medical technologies should be innovative, unique, and have technical feasibility and robust intellectual property. This does not, however, guarantee successful market access and reimbursement.

Despite companies striving to improve patient care, many still struggle to gain market access - governed by three main factors: evidence requirements, the reimbursement landscape and defining clinical and economic value for medical devices.

On 18 November Adelphi Values and two expert speakers, in association with PME, will explain these multiple challenges and discuss key considerations, potential challenges and solutions for gaining successful market access for often life-changing medical technologies.

I would like to invite you to register for this webinar - either to watch it live on the day or for access to a recorded version.